P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
BTIG Downgrades P3 Health Partners Inc (PIII) to Neutral
April 1, 2024 5:35 AM EDTBTIG analyst David Larsen downgraded P3 Health Partners Inc (NASDAQ: PIII) from Buy to Neutral.
The analyst comments "On Thursday, 3/28/24 AMC, PIII reported 4Q:23 results. Revenue of $346.9M +34% y/y exceeded BTIG / consensus estimates of $300M / $303M but adjusted EBITDA of ($44.3M) was well below BTIG / consensus estimates of ($8.4M) / ($4M). Given the higher than expected medical claims costs, increases in reserves, lack of visibility, and fairly tight cash position, we are downgrading PIII to Neutral. We worry that with... More



